Laurence Reid, Ph.D.
Laurence focuses on drug discovery and development opportunities at Third Rock, and serves as acting CEO at Decibel Therapeutics. He first joined Third Rock in 2015 and subsequently assumed the role of CEO of Warp Drive Bio. Prior to that he worked as the Senior Vice President and Chief Business Officer at Alnylam Pharmaceuticals. Before his position at Alnylam, Laurence was the Chief Business Officer at Ensemble Discovery, where he led the company’s strategic planning and corporate development efforts. Laurence previously spent ten years at Millennium Pharmaceuticals in a range of general management and business development positions.
In addition to his professional interests, Laurence is a board member of the Possible Project and board advisor to Life Science Cares.
- B.A., Natural Sciences, University of Cambridge
- Ph.D., Biochemistry, University of London
- East Coast